InsiderTrades

Form 4 for PRVA Privia Health Group, Inc.

Accepted 2022-01-07 00:00:00 ET · period of report 2022-01-05 · accession 0001759655-22-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-01-07 2022-01-05 PRVA Mountcastle David CFO S - Sale+OE $25.53 -16.4K 28.0K -37% -$418.5K
D 2022-01-07 2022-01-05 PRVA Mountcastle David CFO M - OptEx $2.00 +21.6K 44.4K +94% +$43.1K
D 2022-01-07 2022-01-05 PRVA Mountcastle David CFO M - OptEx $0.00 -21.6K 107.8K -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.01 par value per share 2022-01-05 S D 16,391 $25.53 27,989 D — — (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.96 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
2 Common Common Stock, $0.01 par value per share 2022-01-05 M A 21,554 $2.00 44,380 D — —
3 Derivative Stock Option (Right to Purchase) 2022-01-05 M D 21,554 $0.00 107,774 D $2.00 · — to 2029-03-31 21,554 Common Stock (F3) These stock options to purchase shares of common stock of the Issuer were granted under the Second Amended and Restated PH Group Parent Corp. Stock Option Plan. 62,508 of the stock options are fully vested and exercisable. The remaining stock options vest as follows: 10,778 vest on April 1, 2022, 17,244 vest on April 29, 2022 and 17,244 vest on October 29, 2022.